Kyushu University Academic Staff Educational and Research Activities Database
List of Presentations
Isamu Okamoto Last modified date:2019.06.25

Lecturer / Research Institute for Disease of the Chest, Graduate School of Medical Sciences, Kyushu University / Respiratory Medicine / Kyushu University Hospital


Presentations
1. 岡本勇, ASCO/JSMO Joint Symposium
Combination therapy with molecularly targeted agents in lung cancer

, 第15回日本臨床腫瘍学会学術集会, 2017.07.
2. 岡本 勇, Recent advances in the treatment of metastatic NSCLC
-Ready for molecular-based treatment-

, 4th Singapore Society of Oncology and Chapter of Medical Oncologist Review, 2012.02.
3. Okamoto I., Best of Molecular-Targeted Therapy –ASCO2012-

, Best of ASCO 2012 in Japan, 2012.07.
4. Okamoto I., Beyond EGFR-TKI based combination therapy for overcoming acquired resistance
, 4th West Japan Oncology Group International Symposium, 2012.04.
5. Okamoto I., Great clinical impact of molecular-targeted therapy against driver
gene alterations in advanced non-small-cell lung cancer (NSCLC)

, 第52回日本呼吸器学会学術講演会 International Symposium, 2012.04.
6. Okamoto I., Challenging topics in the development of driver oncogene targeted therapies

, IASLC Local Symposium, 2012.10.
7. Okamoto I., Phase II study of oral S-1 and carboplatin plus bevacizumab with maintenance S-1 and bevacizuab as first-line therapy for advanced non-squamous non-small-cell lung cancer
, 5th Asian Pacific Lung Cancer Congress(APLCC), 2012.02.
8. Okamoto I., Potential combination of EGFR-TKIs and survivin suppressor
For EGFR-mutant advanced non-small-cell lung cancer

, 2nd Japan Taiwan Oncology Phase I Trial Conference (JTOPIC), 2013.03.
9. Okamoto I., Non-Small-Cell-Lung Cancer: Molecular target

, Best of ASCO2013 in Japan, 2013.07.
10. Okamoto I., ASCO/JSMO joint symposium
Biomarker analyses in clinical trials for NSCLC
~ West Japan Oncology Group (WJOG) perspective ~
, 第11回日本臨床腫瘍学会学術集会, 2013.08.
11. Okamoto I., JCA-JSMO Joint Symposium
Clinical challenge for therapy based on the cancer specific genomic alterations in advanced NSCLC

, 第72回日本癌学会学術総会, 2013.10.
12. Okamoto I., Multiplexed Genomic Profiling of Non-Small-Cell Lung Cancer(NSCLC)

, 11th International Conference of the Asian Clinical Oncology Society (ACOS), 2014.05.
13. 岡本 勇, ESMO/JSCO Joint Symposium
A new era of genotype-based targeted therapies for advance non-small-cell lung cancer

, 第52回日本癌治療学会学術集会, 2014.08.
14. Okamoto I., Safety Data Analyses For First-Line Pemetrexed Plus Carboplatin in Nonsquamous Non-Small Cell Lung Cancer (ns-NSCLC), European Society of Medical Oncology(ESMO), 2014.09.
15. Okamoto I., Safety Data Analyses For First-Line Pemetrexed Plus Carboplatin in Nonsquamous Non-Small Cell Lung Cancer (ns-NSCLC), Chicago Multidisciplinary Symposium in Thoracic Oncology, 2014.10.